Results 51 to 60 of about 7,766,095 (306)

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya   +10 more
wiley   +1 more source

The RHD Action Small Grants Programme: Small Investment, Big Return!

open access: yesGlobal Heart, 2021
Rheumatic Heart Disease (RHD) remains endemic in low- and middle-income countries (LMICs) despite its virtual elimination in high-income countries. RHD Action was launched to amplify global efforts to control RHD in 2015 by World Heart Federation and ...
Leila Abdullahi   +6 more
doaj   +1 more source

Linfield\u27s Asian Reach [PDF]

open access: yes, 2010
Since the earliest days of its international programs, Linfield has forged connections with Asian counterparts—one relationship at a time.
Linfield Magazine Staff
core   +1 more source

Exploring Preferences for a Digital Single‐Session Intervention for Adolescent Siblings of Youth With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro   +10 more
wiley   +1 more source

Palm-based Oleochemicals in Non-Food Applications: Meeting the Environmental Regulatory Challenges

open access: yesASM Science Journal, 2021
The oleochemical manufacturing is one of the industrial sectors that contributed significantly to the economic growth of the country. Palm oil (PO) and palm kernel oil (PKO) have been utilised as feedstocks for production of the five basic oleochemicals,
Razmah Ghazali   +3 more
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Reach - an overview [PDF]

open access: yesInterdisciplinary Toxicology, 2009
Reach - an overview An outline of the new European policy in the management of chemicals is given. This new system is known under the acronym REACH which stands for Registration, Evaluation and Authorisation of Chemicals. The background, objectives, requirements and the operation of REACH are briefly explained.
openaire   +2 more sources

Extending the Reach of Hydrodynamics

open access: yes, 2007
Recent and ongoing improvements to hydrodynamic treatments at RHIC are extending the physics reach of hydrodynamics, and improving the phenomenology. Here, the links between technological improvements and the extension of physics are emphasized.Comment ...
Pratt, Scott
core   +1 more source

Grain Survival in Supernova Remnants and Herbig-Haro Objects [PDF]

open access: yes, 2000
By using the flux ratio [FeII]8617/[OI]6300, we demonstrate that most of the interstellar dust grains survive in shocks associated with supernova remnants and Herbig-Haro objects.
Dennefeld M.   +5 more
core   +2 more sources

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy